Quan Liu

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Jie Wang, Caicun Zhou, Wenxiu Yao et al. · The Lancet Oncology · 2022 · 361 citations

Oncology, Pharmacology, Bronchial Neoplasm +5

DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation

Yu‐Shui Ma, Zhi‐Jun Wu, Ruizhen Bai et al. · Cancer Letters · 2018 · 35 citations

Epithelial-mesenchymal Transition, Glioma, Medicine +8

Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes

Linjuan Zhang, Mengmeng Jing, Quan Liu · Life Sciences · 2021 · 35 citations

Inflammation, Oxidative Stress Responses, Anti-inflammatory +12

Flavanols from the Camellia sinensis var. assamica and their hypoglycemic and hypolipidemic activities

Xin Wang, Quan Liu, H. Zhu et al. · Acta Pharmaceutica Sinica B · 2017 · 34 citations · Full text

Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial

Quan Liu, Juan-Ying Xu, Ye-Hong Xu et al. · Translational Lung Cancer Research · 2022 · 19 citations · Full text